文献速递重症综合管理与镇静镇痛

哪些因素与ICU获得性衰弱相关?系统评价与Meta分析的概述

Which factors are associated with acquired weakness in the ICU? An overview of systematic reviews and meta-analyses.
PubMed 文献 · J Intensive Care · 2024-09-05
一句话结论高龄、女性、多器官衰竭与ICU获得性衰弱持续相关;神经肌肉阻滞剂、高血糖、皮质类固醇证据矛盾,氨基糖苷类、肾脏替代治疗、去甲肾上腺素相关但异质性高。

该概述纳入了18篇系统评价,涵盖24个ICU获得性衰弱(ICUAW)危险因素,其中15个因素进行了Meta分析。12篇综述偏倚风险低,4篇不明确,2篇高。不可干预因素如高龄、女性、多器官衰竭与ICUAW持续相关;可干预因素如神经肌肉阻滞剂、高血糖、皮质类固醇结果矛盾;氨基糖苷类、肾脏替代治疗、去甲肾上腺素与ICUAW相关但异质性高。结论指出多种危险因素需在防治策略中考虑,部分因素结果矛盾或探索不足,强调需要个性化研究。

要点

  • 不可干预因素:高龄、女性、多器官衰竭与ICUAW持续相关。
  • 可干预因素:神经肌肉阻滞剂、高血糖、皮质类固醇与ICUAW关系结果矛盾。
  • 氨基糖苷类、肾脏替代治疗、去甲肾上腺素与ICUAW相关,但异质性高。
  • 18篇系统评价中,12篇偏倚风险低,4篇不明确,2篇高。
  • 24个危险因素中仅15个有Meta分析,其余为定性总结。

适用人群与场景

  • 重症患者,用于评估ICU获得性衰弱(ICUAW)的危险因素。

研究设计与关键结果

  • 研究类型:系统评价的概述,检索6个数据库,纳入18篇系统评价,涵盖24个ICUAW危险因素。
  • 偏倚风险:12篇综述低风险,4篇不明确,2篇高风险。
  • 重叠程度:校正覆盖面积指数范围为0至23%。
  • 不可干预因素:高龄、女性、多器官衰竭与ICUAW持续相关。
  • 可干预因素:神经肌肉阻滞剂、高血糖、皮质类固醇与ICUAW关系结果矛盾。
  • 氨基糖苷类、肾脏替代治疗、去甲肾上腺素与ICUAW相关,但异质性高。

证据类型、等级与局限

  • 证据类型:系统评价的概述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为:多种与ICUAW相关的危险因素应在预防和治疗策略中加以考虑。
  • 作者认为:部分危险因素结果矛盾,若干因素探索不足,强调需要涵盖ICUAW所有潜在 contributing 因素的个性化研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

RATIONALE: Intensive care unit-acquired weakness (ICUAW) is common in critically ill patients, characterized by muscle weakness and physical function loss. Determining risk factors for ICUAW poses challenges due to variations in assessment methods and limited generalizability of results from specific populations, the existing literature on these risk factors lacks a clear and comprehensive synthesis.

OBJECTIVE: This overview aimed to synthesize risk factors for ICUAW, categorizing its modifiable and nonmodifiable factors.

METHODS: An overview of systematic reviews was conducted. Six relevant databases were searched for systematic reviews. Two pairs of reviewers selected reviews following predefined criteria, where bias was evaluated. Results were qualitatively summarized and an overlap analysis was performed for meta-analyses.

RESULTS: Eighteen systematic reviews were included, comprising 24 risk factors for ICUAW. Meta-analyses were performed for 15 factors, while remaining reviews provided qualitative syntheses. Twelve reviews had low risk of bias, 4 reviews were unclear, and 2 reviews exhibited high risk of bias. The extent of overlap ranged from 0 to 23% for the corrected covered area index. Nonmodifiable factors, including advanced age, female gender, and multiple organ failure, were consistently associated with ICUAW. Modifiable factors, including neuromuscular blocking agents, hyperglycemia, and corticosteroids, yielded conflicting results. Aminoglycosides, renal replacement therapy, and norepinephrine were associated with ICUAW but with high heterogeneity.

CONCLUSIONS: Multiple risk factors associated with ICUAW were identified, warranting consideration in prevention and treatment strategies. Some risk factors have produced conflicting results, and several remain underexplored, emphasizing the ongoing need for personalized studies encompassing all potential contributors to ICUAW development.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Fuentes-Aspe R, Gutierrez-Arias R, González-Seguel F, et al. Which factors are associated with acquired weakness in the ICU? An overview of systematic reviews and meta-analyses. J Intensive Care. 2024. PMID: 39232808. doi:10.1186/s40560-024-00744-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。